Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Intelligent Bio Solutions Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 8 | 14 | +6 |
| Shares | 447.8K | 597.5K | +149.7K (+33.4%) |
| Value | $151.3K | $2.52M | +$2.36M (+1,562.9%) |
New holders (10)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 206,199 | $864.2K | 0.01% |
| Hudson Bay Capital Management LP | 108,250 | $456.8K | 0.00% |
| CVI Holdings, LLC | 108,250 | $456.8K | 0.43% |
| ADAR1 Capital Management, LLC | 108,250 | $456.8K | 0.12% |
| Vanguard Group Inc | 15,485 | $65.3K | 0.00% |
| Virtu Financial LLC | 12,537 | $53.0K | 0.00% |
| Citigroup Inc | 7,960 | $33.6K | 0.00% |
| UBS Group AG | 348 | $1.47K | 0.00% |
| Headlands Technologies LLC | 26 | $110 | 0.00% |
| JPMorgan Chase & Co | 4 | $17 | 0.00% |
Sold out (4)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Renaissance Technologies LLC | 147,568 | $50.0K |
| Omers Administration Corp | 42,500 | $14.3K |
| Two Sigma Investments, LP | 34,089 | $11.5K |
| Two Sigma Securities, LLC | 29,441 | $9.95K |